Physician profile
David Q Phan
NPI 1295098846
$4,724.07
in general payments reported to CMS, 2019-2025
11 companies · $2,121 in 2025
The $2,121 reported for 2025 was more than what 92% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,562 · 2020: $24.95 · 2021: $17.48 · 2022: $803 · 2023: $120 · 2024: $76.01 · 2025: $2,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632 · Travel and Lodging: $599 · Education: $50.00 · Gift: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,632.35 |
| Travel and Lodging | $599.34 |
| Education | $50.00 |
| Gift | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,990.16 | 2024-2025 | |
| Stryker Corporation | $1,562.02 | 2019 | |
| Implant Direct Sybron International LLC | $436.74 | 2022 | |
| Straumann USA LLC | $295.45 | 2022-2025 | |
| Geistlich Pharma, North America, INC. | $129.82 | 2025 | Biomaterials |
| Acelrx Pharmaceuticals, INC. | $118.40 | 2022 | |
| Nobel Biocare USA | $77.32 | 2021-2023 | Nobelactive |
| Biohorizons Implant Systems INC. | $41.85 | 2024 | Biohorizons |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $28.86 | 2023 | Allooss Allograft Putty |
| Zimmer Biomet Holdings, INC. | $24.95 | 2020 | |
| Orapharma, A Division of Bausch Health US, LLC | $18.50 | 2023 | Ossix Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.